Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Simona Landoni"'
Autor:
Enrico Ragni, Paola De Luca, Simona Landoni, Federico Valli, Leonardo Mortati, Silvia Palombella, Giuseppe Talò, Matteo Moretti, Laura de Girolamo
Publikováno v:
Regenerative Therapy, Vol 26, Iss , Pp 442-457 (2024)
Introduction: Extracellular vesicles from mesenchymal stromal cells (MSC-EVs) are potent stimulators of naïve cartilage and their injection is studied in clinical trials for cartilage lesions, since often cartilage repaired with conventional approac
Externí odkaz:
https://doaj.org/article/0b036a6a8fde4602aa7c67f0accd68f7
Autor:
Sara Giordana Rimoldi, Davide Brioschi, Daniele Curreli, Federica Salari, Cristina Pagani, Alessandro Tamoni, Concetta Longobardi, Raffaella Bosari, Alberto Rizzo, Simona Landonio, Massimo Coen, Matteo Passerini, Maria Rita Gismondo, Andrea Gori, Alfonso Manzotti
Publikováno v:
Antibiotics, Vol 12, Iss 11, p 1588 (2023)
(Background) The diagnosis and the antimicrobial treatment of orthopedic infection are challenging, especially in cases with culture-negative results. New molecular methods, such as next-generation sequencing (NGS), promise to overcome some limitatio
Externí odkaz:
https://doaj.org/article/7a1df9f152404ddaabe9ac53e9547419
Autor:
Cristina Gervasoni, Paola Meraviglia, Davide Minisci, Laurenzia Ferraris, Agostino Riva, Simona Landonio, Valeria Cozzi, Nitin Charbe, Lara Molinari, Giuliano Rizzardini, Emilio Clementi, Massimo Galli, Dario Cattaneo
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123670 (2015)
INTRODUCTION:Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia, dyslipidemia, nephrolithiasis and cholelithiasis have been reported in the medium and long term.
Externí odkaz:
https://doaj.org/article/40ca34b757d54a3396f5136cc04feec0
Autor:
Cristina Gervasoni, Paola Meraviglia, Simona Landonio, Sara Baldelli, Serena Fucile, Laura Castagnoli, Emilio Clementi, Agostino Riva, Massimo Galli, Giuliano Rizzardini, Dario Cattaneo
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e80242 (2013)
Treatment with tenofovir sometimes leads to non-reversible kidney and/or bone diseases. Factors associated with these drug-related adverse events are poorly characterized. Our objective was to investigate such factors in patients treated long term wi
Externí odkaz:
https://doaj.org/article/785560192a1748af8ac6112cdf0ed7a3
Autor:
Amedeo Capetti, Simona Landonio, Paola Meraviglia, Antonio Di Biagio, Sergio Lo Caputo, Gaetana Sterrantino, Adriana Ammassari, Barbara Menzaghi, Marco Franzetti, Giuseppe Vittorio De Socio, Giovanni Pellicanò, Elena Mazzotta, Alessandro Soria, Marianna Meschiari, Michele Trezzi, Lolita Sasset, Benedetto Maurizio Celesia, Patrizia Zucchi, Sara Melzi, Elena Ricci, Giuliano Rizzardini
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e39222 (2012)
BackgroundLong term efficacy of raltegravir (RAL)-including regimens in highly pre-treated HIV-1-infected patients has been demonstrated in registration trials. However, few studies have assessed durability in routine clinical settings.MethodsAntiret
Externí odkaz:
https://doaj.org/article/fcec1bdc8aa6404abf2b96fb1dc669cc